Thursday, November 3, 2016 | 9:00 AM - 5:00 PM
Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Louvain Drug Research Institute, Metabolism and Nutrition), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)
The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.
Friday, December 2, 2016 | 12:30 PM - 6:30 PM
Speakers: Jan van Deursen (The Mayo Clinic), Vadim Gladyshev (Harvard University), Steven Horvath (University of California Los Angeles), Matt Kaeberlein (University of Washington), Vera Gorbunova (University of Rochester), and Arlan Richardson (University of Oklahoma)
To explore the interplay between aging, nutrition, and metabolism, as well as the important role that novel technologies will play in current and future studies, we are bringing together several preeminent researchers in these fields.
Friday, September 16, 2016 | 8:30 AM - 6:00 PM
Speakers: Lori B. Andrews (Chicago-Kent College of Law, Illinois Institute of Technology), Gary Bennett (Duke University), Barbara E. Millen (Millennium Prevention, Inc.), Tooraj Mirshahi (Geisinger Clinic), Satchidananda Panda (SALK Institute), Ruth E. Patterson (University of California San Diego), Michael K. Price (Georgia State University), Karandeep Singh (University of Michigan), and Nicholas Tatonetti (Columbia University)
Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?
Friday, June 3, 2016 | 8:30 AM - 6:00 PM
Speakers: Agnes C. Agunos (Public Health Agency of Canada), Seamus Fanning (University College Dublin), Delia Grace (International Livestock Research Institute), William J. Hall (Wellcome Trust), Francois Malouin (Sherbrooke University), James L. Marsden (Chipotle Mexican Grill), Alan G. Mathew (Purdue University), H. Morgan Scott (Texas A&M University), Stacy E. Sneeringer (USDA), Jaap A. Wagenaar (Utrecht University), and David R. Wolfgang (Pennsylvania State University)
Antibiotics have been used in human and animal medicine for decades. Reducing the use of antibiotics changes the dynamic between the food supply, food safety, and public health. Food safety practices may emerge a catalyst for change.
May 10 - 12, 2016 | United Kingdom
Keynote Speakers: John Bienenstock (McMaster University) and Jeffrey Gordon (Washington University in St. Louis – via Skype)
The human body is colonized by a vast number of commensal organisms, collectively termed the microbiome. Importantly, dysbiosis — dyregulation of this endemic microbiome — has been implicated in a myriad of human diseases ranging from inflammatory bowel disease, to depression.
Tuesday, March 15, 2016 | 8:30 AM - 5:00 PM
Speakers: Premysl Bercik (McMaster University Medical Centre), John F Cryan (University College Cork), Ted Dinan (University College Cork), Emeran Mayer (David Geffen School of Medicine, UCLA), Sarkis Mazmanian (California Institute of Technology), Vassilis Pachnis, MD (The Francis Crick Institute), Robert Yolken (John Hopkins School of Medicine)
The gut microbiome is emerging as an important regulator of brain development, brain health, and disease. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on CNS health.
Edited by Karin Moelling (University of Zurich)
Discussions of the link between nutrition and the gut microbiome
Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.
Edited by Annals of the New York Academy of Sciences
Continuation of over four decades of scientific discussion on Cooley's anemia published in Annals of the New York Academy of Sciences
Organizers: David Evans (Ohio State University), Refaat Hegazi (Abbott Nutrition Health Institute), Gerard Mullin (Johns Hopkins Medicine), Dennis H. Sullivan (University of Arkansas for the Medical Sciences), Kathy West (Abbott Nutrition Health Institute), Amy R. Beaudreault (The Sackler Institute for Nutrition Science), and Julie Shlisky (The Sackler Institute for Nutrition Science)
This eBriefing reviews interventions for disease-related muscle mass loss.